ELI LILLY AND COMPANY Payment for Pension and Other Postretirement Benefits
ELI LILLY AND COMPANY (LLY) reported Payment for Pension and Other Postretirement Benefits of $80.00 million for the 12-month period ending 2011-12-31, per its 10-K filed 2011-02-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PensionAndOtherPostretirementBenefitContributions · last filed 2011-10-28
- ELI LILLY AND COMPANY payment for pension and other postretirement benefits for the quarter ending 2011-12-31 was $0.00.
- ELI LILLY AND COMPANY payment for pension and other postretirement benefits for the quarter ending 2011-09-30 was -$20.00M, a 120.00% decline year-over-year.
- ELI LILLY AND COMPANY payment for pension and other postretirement benefits for the quarter ending 2011-06-30 was $50.00M, a 50.00% decline year-over-year.
- ELI LILLY AND COMPANY payment for pension and other postretirement benefits for the quarter ending 2011-03-31 was $50.00M.
- ELI LILLY AND COMPANY payment for pension and other postretirement benefits for fiscal 2011 was $80.00M.
| Period end | Payment for Pension and Other Postretirement Benefits 3 month | Payment for Pension and Other Postretirement Benefits 6 month | Payment for Pension and Other Postretirement Benefits 9 month | Payment for Pension and Other Postretirement Benefits 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | -$20.00M derived: sum of 2 quarters · filed 2011-02-22 | $30.00M derived: sum of 3 quarters · filed 2011-07-29 | $80.00M 10-K · filed 2011-02-22 |
| 2011-09-30 | -$20.00M derived: 10-K 12 month − 3 quarters · filed 2011-02-22 | $30.00M derived: sum of 2 quarters · filed 2011-07-29 | $80.00M 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $50.00M 10-Q · filed 2011-07-29 | $100.00M derived: sum of 2 quarters · filed 2011-07-29 | ||
| 2011-03-31 | $50.00M 10-Q · filed 2011-04-29 | |||
| 2010-09-30 | $100.00M 10-Q · filed 2010-10-29 | $200.00M derived: sum of 2 quarters · filed 2010-10-29 | ||
| 2010-06-30 | $100.00M 10-Q/A · filed 2010-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |